Medicine and Dentistry
Aciclovir
11%
Adverse Event
5%
Alcohol Abstinence
7%
Alcohol Consumption
13%
Arm
7%
Carnitine
11%
Checklist
9%
Cleft Palate
6%
Clinical Trial
19%
Clinician
22%
Controlled Clinical Trial
10%
Critical Appraisal
8%
Dental Caries
6%
Dental Practice
20%
Dental Procedure
13%
Dentistry
15%
Disability Adjusted Life Years
9%
Diseases
10%
Drug Use
11%
Global Disease Burden
8%
Group Trial
21%
Health Behavior
5%
Health Care
16%
Health Care Cost
16%
Health Service
11%
Health System
8%
Herpetic Stomatitis
11%
Inborn Error of Metabolism
11%
Injury
6%
Lifespan
11%
Lower Jaw
8%
Malocclusion
5%
Mandible Fracture
8%
Meta-Analysis
6%
Mouthwash
5%
Oral Cavity
6%
Oral Submucous Fibrosis
11%
Osteoarthritis
5%
Permanent Tooth
26%
Physical Activity
17%
Placebo
16%
Primary Health Care
10%
Random Effects Model
7%
Randomized Controlled Trial
51%
Root Canal
24%
Substance Use
6%
Supplementation
11%
Systematic Review
100%
Tooth Resorption
5%
Wellbeing
5%
Nursing and Health Professions
Absence
7%
Action Research
5%
Adrenergic Receptor Stimulating Agent
5%
Aerosol
17%
Base
13%
Beta 2 Adrenergic Receptor
5%
Biomedical Technology Assessment
5%
Carnitine
11%
Checklist
13%
Chronic Disease
5%
Cleft Palate
5%
Clinical Effectiveness
5%
Clinician
10%
Cochrane Library
17%
Confidence Interval
7%
Consumer
5%
Critical Appraisal
9%
Dental Practice
20%
Dental Procedure
10%
Disease
12%
Dysmenorrhea
5%
Epidemiology
5%
Face Fracture
5%
Health Care Concepts
5%
Health Care Policy
17%
Health Outcomes
11%
Health Program
5%
Health Service
10%
Healthcare Consumer
5%
Healthcare Research
5%
Inborn Error of Metabolism
11%
Meta Analysis
5%
Morbidity
5%
Mouth Disease
5%
Mouthwash
17%
Necrosis
5%
Palatopharyngeal Incompetence
5%
Patient Participation
5%
Patient Preference
11%
Physician
18%
Placebo
9%
Practice Guideline
10%
Primary Health Care
5%
Primary Medical Care
16%
Protective Equipment
5%
Pulpitis
5%
Randomization
11%
Supplementation
11%
Systematic Review
46%
Tonsillectomy
17%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
14%
Adrenergic Receptor Stimulating Agent
5%
Antihistaminic Agent
5%
Beta 2 Adrenergic Receptor
5%
Bleeding
8%
Botulinum Toxin
5%
Carnitine
11%
Clinical Trial
21%
Controlled Clinical Trial
10%
Dental Caries
5%
Disease
11%
Dysmenorrhea
5%
Ethanol
5%
Face Fracture
5%
Global Disease Burden
6%
Group Trial
12%
Halitosis
5%
Herpetic Stomatitis
17%
Inborn Error of Metabolism
11%
Injury
6%
Ionizing Radiation
5%
Mandible Fracture
5%
Mouth Disease
5%
Mouthwash
23%
Nose Disease
5%
Perennial Rhinitis
5%
Placebo
24%
Pollen Allergy
5%
Randomized Controlled Trial
44%
Side Effect
5%
Skin Disease
5%
Throat Disease
5%
Tooth Disease
5%
Vasomotor Rhinitis
5%
